Instinct Bio Hit With Three Nasdaq Delisting Notices
BIOT is trading near its 52-week low of $0.36 (0.0% above the low) on light trading volume (0.1× avg).
Summary
Instinct Bio disclosed three Nasdaq delisting notices for failing minimum bid price, market value of listed securities, and market value of publicly held shares requirements. The company has until March 2027 to regain compliance.
Key Events · Legal and Risk Events · BIOT
-
Three Nasdaq Delisting Notices Received
Nasdaq notified Instinct Bio on September 9-10, 2026 of non-compliance with MVLS (below $50M), MVPHS (below $15M), and Bid Price (below $1.00) requirements.
-
180-Day Compliance Window
Company has until March 8-9, 2027 to regain compliance; bid price must close at or above $1.00 for 10 consecutive business days.
-
Delisting Risk
If compliance is not regained, Nasdaq will issue delisting notification; company may appeal or transfer to Nasdaq Capital Market.
-
Reverse Split Under Consideration
Company may pursue a reverse share split to cure the bid price deficiency, subject to Nasdaq Capital Market transfer requirements.
Analysis · BIOT · Industrial Applications And Services
Instinct Bio received three separate Nasdaq non-compliance notices on September 9-10, 2026: market value of listed securities below $50M, market value of publicly held shares below $15M, and bid price below $1.00. The stock trades at $0.36, near its 52-week low, and the company has 180 days (until March 8-9, 2027) to regain compliance or face delisting. This is a critical governance and listing risk event for a company that recently completed a SPAC merger and announced a $150M equity facility — the delisting threat directly undermines its ability to access that capital and maintain investor confidence.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 39.9% of the 323 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BIOT was trading at $0.36 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $10.4M. The 52-week trading range was $0.36 to $50.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.